We are pleased to announce that Argus Partners has advised Infinx on its acquisition of Glidian, Inc., a market leader in prior authorization automation, through a reverse triangular merger.

Established in 2012, Infinx provides scalable, AI-driven solutions that optimize the financial lifecycle of healthcare providers, covering patient access and revenue cycle management. Its cloud-based, AI-powered software is leveraged by experienced consultants and billing specialists across the U.S., India, and the Philippines.

This strategic acquisition strengthens Infinx’s patient access solutions while expanding its presence in the laboratory market, where Glidian has established itself as a leader.

The integration of Glidian into Infinx comes at a crucial juncture. Both companies have developed integrations with several nationwide payers, and by combining these networks, they aim to enhance efficiency and streamline workflows for customers. Together, Infinx and Glidian now process an average of 700,000 patient access transactions per month, solidifying their position as a leader in patient access automation.

Glidian customers will benefit from Infinx’s advanced AI capabilities, leading to enhanced automation, improved accuracy, and faster prior authorization approvals. Infinx’s AI-driven platform continuously learns and adapts to payer requirements, reducing administrative burdens and helping healthcare organizations optimize their workflows. The combination of AI-powered intelligence with Glidian’s established solutions will deliver a seamless and more efficient prior authorization process.

Commenting on the acquisition, Jaideep Tandon, CEO of Infinx, said, “Glidian’s expertise in prior authorization technology, particularly in the laboratory space, perfectly complements Infinx’s comprehensive suite of patient access solutions. We are excited to welcome the Glidian team to the Infinx family and look forward to continuing our commitment to innovation in addressing the challenges of patient access and prior authorization. Together, we will create even greater value for healthcare providers and their patients.”

The team at Argus Partners advising Infinx consisted of, Abhinav Bhalaik, Vallishree Chandra (Partners), Rohan Aneja (Senior Associate), and Kanishk Gambhir (Associate).